NCT03744182View on ClinicalTrials.gov

A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

March 18, 2020

Study Completion Date

March 18, 2020

Conditions
NAFLD
Interventions
DRUG

HM15211

A sterile solution of HM15211 contained in pre-filled syringes

DRUG

Placebo of HM15211

A sterile, matching solution in pre-filled syringes

Trial Locations (1)

91911

ProSciento Inc., Chula Vista

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY